pre-IPO PHARMA

COMPANY OVERVIEW

LifeMine Therapeutics is pioneering a genomically-enabled drug discovery approach integrating advanced life science and computational technologies to elucidate human biology and create sophisticated therapeutics that attack the fundamental drivers of serious human diseases.


LOCATION

  • Cambridge, MA, USA
  • New York, NY, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://lifeminetx.com


    CAREER WEBSITE

    https://lifeminetx.com/#careers


    SOCIAL MEDIA


    INVESTORS

    alexandria-venture-investments arch-venture-partners blue-pool-capital boyu-capital foresite-capital gv mrl-ventures-fund wuxi-healthcare-ventures


    PRESS RELEASES


    Mar 23, 2022

    LifeMine Therapeutics Announces $175 Million Series C Financing


    Jan 7, 2021

    LifeMine Therapeutics Announces $50 Million Series B Financing


    Oct 18, 2019

    LifeMine Therapeutics Powers Drug Discovery Team to Search the Biosphere for Nature's Evolved Solutions to Intractable Therapeutic Challenges


    Sep 18, 2017

    LifeMine Therapeutics Launches with $55 Million Series A Financing


    For More Press Releases


    Google Analytics Alternative